State Street® SPDR® S&P® Biotech ETF XBI

Morningstar Medalist Rating

Morningstar’s Analysis XBI

Will XBI outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street® SPDR® S&P® Biotech ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XBI

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings18.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

2.46242M
Healthcare

Biogen Inc

1.85182M
Healthcare

Amgen Inc

1.83180M
Healthcare

Regeneron Pharmaceuticals Inc

1.83180M
Healthcare

AbbVie Inc

1.82179M
Healthcare

United Therapeutics Corp

1.80177M
Healthcare

Gilead Sciences Inc

1.79175M
Healthcare

Exelixis Inc

1.78175M
Healthcare

TG Therapeutics Inc

1.78175M
Healthcare

Spyre Therapeutics Inc

1.77174M
Healthcare

Sponsor Center